PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFurazolidone
Furazolidone
Furoxone (furazolidone) is a small molecule pharmaceutical. Furazolidone was first approved as Furoxone on 1982-01-01. It is used to treat animal salmonella infections, bacillary dysentery, cholera, diarrhea, and enteritis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
animal diseasesD000820
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Furazolidone
Tradename
Company
Number
Date
Products
FUROXONEShireN-011270 DISCN1982-01-01
1 products
FUROXONEShireN-011323 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
G01: Gynecological antiinfectives and antiseptics
G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AX: Other gynecological antiinfectives and antiseptics in atc
G01AX06: Furazolidone
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01A: Agents against amoebiasis and other protozoal diseases
P01AB: Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases
P01AB51: Metronidazole and furazolidone
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameFurazolidone
INNfurazolidone
Description
Furazolidone is a nitrofuran antibacterial agent and monoamine oxidase inhibitor (MAOI). It is marketed by Roberts Laboratories under the brand name Furoxone and by GlaxoSmithKline as Dependal-M.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1
Identifiers
PDB
CAS-ID67-45-8
RxCUI
ChEMBL IDCHEMBL1103
ChEBI ID
PubChem CID3435
DrugBankDB00614
UNII ID5J9CPU3RE0 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Furazolidone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use